Get 20% lifetime commission for referring investors to digrin.com
here.
ImmuCell Corporation (ICCC) Financials
ICCC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 46.6 million | 10.8 million |
| March 31, 2026 | 44.1 million | 15.0 million |
| Dec. 31, 2025 | 42.5 million | 15.5 million |
| Sept. 30, 2025 | 45.7 million | 15.9 million |
ICCC Free Cash Flow and Stock based compensation
No data available :(
ICCC Net Income
No data available :(
ICCC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.9 million | 4.0 million | - |
| March 31, 2026 | 6.8 million | 7.1 million | 4.1 million |
| Dec. 31, 2025 | 3.8 million | 7.5 million | 4.1 million |
| Sept. 30, 2025 | 3.9 million | 7.9 million | 4.0 million |
ICCC Shares Outstanding
ICCC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 733939 | 119652 | 2.4 million | 1.1 million |
| March 31, 2026 | 177230 | 317688 | 2.4 million | 1.2 million |
| Dec. 31, 2025 | 172306 | 758864 | 2.2 million | 1.1 million |
| Sept. 30, 2025 | 593924 | 694311 | 1.6 million | 919291 |
ICCC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 7.2 million | 4.7 million |
| March 31, 2026 | 10.4 million | 5.7 million |
| Dec. 31, 2025 | 7.6 million | 4.7 million |
| Sept. 30, 2025 | 5.5 million | 3.1 million |
ICCC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ICCC
Price: $9.76
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 143.57
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8519
Ebitda: 1.2 millionMarket Capitalization: 91.3 million